Zellweger syndrome and secondary mitochondrial myopathy
Vincenzo Salpietro1, Rahul Phadke, Anand Saggar
1Department of Paediatric Neurology, Chelsea and Westminster NHS Foundation Trust, London, UK, v.salpietro@imperial.ac.uk.
Insights
Peroxisome defects, like Zellweger syndrome (ZS), can impair mitochondria. This study confirms secondary mitochondrial myopathy in molecularly diagnosed ZS patients, linking peroxisomal disorders to mitochondrial dysfunction.
Area of Science:
- Biochemistry
- Genetics
- Cell Biology
Background:
- Peroxisome biogenesis disorders (PBDs), including Zellweger syndrome (ZS), are a group of severe genetic diseases.
- Defects in peroxisomes disrupt various metabolic pathways, potentially affecting other organelles like mitochondria.
Observation:
- Two infants with Zellweger syndrome exhibited typical clinical, radiological, and laboratory features.
- Muscle biopsies revealed mitochondrial pathology, and genetic analysis identified pathogenic mutations in PEX16 and PEX12 genes.
- Mitochondrial respiratory chain enzymology in one patient showed reduced activity in complexes II-III and IV.
Findings:
- This study presents the first molecularly confirmed cases of peroxisomal disorder with concurrent mitochondrial myopathy.
- Review of five previously reported children with ZS and muscle biopsy findings supports a link between peroxisomal defects and mitochondrial pathology.
Implications:
- Secondary mitochondrial dysfunction is a significant factor in the clinical presentation of Zellweger syndrome.
- Understanding this interplay is crucial for diagnosing and potentially treating patients with PBDs and associated mitochondrial myopathies.
Abstract:
Defects in peroxisomes such as those associated with Zellweger syndrome (ZS) can influence diverse intracellular metabolic pathways, including mitochondrial functioning. We report on an 8-month-old female infant and a 6-month-old female infant with typical clinical, radiological and laboratory features of Zellweger syndrome; light microscopic and ultrastructural evidence of mitochondrial pathology in their muscle biopsies; and homozygous pathogenic mutations of the PEX16 gene (c.460 + 5G > A) and the PEX 12 gene (c.888_889 del p.Leu297Thrfs*12), respectively. Additionally, mitochondrial respiratory chain enzymology analysis in the first girl showed a mildly low activity in complexes II-III and IV. We also review five children previously reported in the literature with a presumptive diagnosis of ZS and additional mitochondrial findings in their muscle biopsies. In conclusion, this is the first study of patients with a molecularly confirmed peroxisomal disorder with features of a concomitant mitochondrial myopathy and underscores the role of secondary mitochondrial dysfunction in Zellweger syndrome, potentially contributing to the clinical phenotype.
Related Concept Videos
ATP Synthase: Mechanism
Myasthenia Gravis ll: Pathophysiology
Animal Mitochondrial Genetics
Secondary Spinal Cord Injury llI: Pathophysiology
Disorders of the Skeletal Muscle
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Alterations in Muscle Tone lll


